Showing results (11-20 of 172) with videos related to
Sort By:
Pageof 18
Women'S Health (London, England)|February 28, 2009
Treatment options for breast cancer and bone metastasesMartin PecherstorferExpert Opinion on Pharmacotherapy|November 14, 2008
Managing neoplastic bone disease with ibandronic acid: a preclinical and clinical data updateMartin PecherstorferCancers|October 23, 2021
Relapsed/Refractory Multiple Myeloma in 2020/2021 and BeyondKlaus Podar, Xavier LeleuCancers|June 2, 2021
The Role of AP-1 Transcription Factors in Plasma Cell Biology and Multiple Myeloma PathophysiologyFengjuan Fan, Klaus PodarExpert Opinion on Biological Therapy|June 18, 2013
New insights, recent advances, and current challenges in the biological treatment of multiple myelomaSonia Vallet, Klaus PodarExpert Opinion on Drug Discovery|February 19, 2024
The preclinical discovery and clinical development of ciltacabtagene autoleucel (Cilta-cel) for the treatment of multiple myelomaIrene Strassl, Klaus PodarBreast Cancer Research and Treatment|October 31, 2018
Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancerSonia Vallet, Fengjuan Fan, Stefano Malvestiti, et al.Cancers|September 10, 2021
Evaluation of Antibody Responses to COVID-19 Vaccines among Solid Tumor and Hematologic PatientsJosef Singer, Nguyen-Son Le, Daniel Mattes, et al.Cell Cycle (Georgetown, Tex.)|April 21, 2010
A therapeutic role for targeting c-Myc/Hif-1-dependent signaling pathwaysKlaus Podar, Kenneth C AndersonCancer Letters|February 14, 2006
Caveolin-1 as a potential new therapeutic target in multiple myelomaKlaus Podar, Kenneth C AndersonPageof 18